ANH-Intl News Alerts: Week 26, 2014

Sun exposure, whooping cough vaccine, HIV vaccine researcher arrest, BBC science coverage bias, fracking, UK sugar tax, botanicals in France and Alzheimer’s
Source: Alliance for Natural Health - Category: Complementary Medicine Authors: Tags: Alzheimer & #039;s arrest BBC science coverage botanicals europe fracking France HIV international news alerts snippets sugar tax sun exposure UK vaccine whooping cough Source Type: news

Related Links:

Authors: Barber MRW, Clarke AE Abstract INTRODUCTION: Systemic lupus erythematosus (SLE) is an autoimmune disorder that affects almost every organ system and it is treated with immunomodulation and immunosuppression. SLE patients have an intrinsically dysfunctional immune system which is exacerbated by disease activity and leaves them vulnerable to infection. Treatment with immunosuppression increases susceptibility to infection, while hydroxychloroquine use decreases this risk. Infectious diseases are a leading cause of hospitalization and death. AREAS COVERED: This narrative review provides an overview of rec...
Source: Expert Review of Clinical Immunology - Category: Allergy & Immunology Tags: Expert Rev Clin Immunol Source Type: research
Authors: Alanagreh L, Alzoughool F, Atoum M Abstract The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the disease, the antimalarial drug hydroxychloroquine (HCQ) obtained much attention as a treatment for COVID-19. However, there are limited and uncertain clinical data to support the beneficial effect of this drug in COVID-19 treatment. HCQ has several side effects and warnings, including blindness, heart failure, and renal toxicity, even with recommended doses. For severe cases of COVID-19 or in patients with preexisting condition...
Source: International Journal of Risk and Safety in Medicine - Category: Drugs & Pharmacology Tags: Int J Risk Saf Med Source Type: research
Authors: Lozupone M, La Montagna M, Sardone R, Seripa D, Daniele A, Panza F PMID: 32475180 [PubMed - as supplied by publisher]
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research
Our “hidden enemy,” in plain sight.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science SARS (Severe Acute Respiratory Syndrome) Coronavirus (2019-nCoV) Research Proteins Microbiology Immune System Vaccination and Immunization RNA (Ribonucleic Acid) Biology and Biochemistry your-feed-health Nature Medi Source Type: news
Publication date: Available online 1 June 2020Source: Neurología (English Edition)Author(s): T. Zúñiga Santamaría, P. Yescas Gómez, I. Fricke Galindo, M. González González, A. Ortega Vázquez, M. López López
Source: Neurologia - Category: Neurology Source Type: research
Condition:   Alzheimer's Disease With PSEN1 Mutations Interventions:   Drug: Bromocriptine;   Drug: Placebos Sponsors:   Kyoto University;   Mie University;   Osaka University;   Tokushima University;   Tokyo Metropolitan Geriatric Medical Center;   Asakayama General Hospital;   Kawasaki Medical School Hospital;   Time Therapeutics, Inc.;   Towa Pharmaceutical Co.,Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   COVID-19 Interventions:   Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule;   Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule;   Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule;   Biological: Medium dosage Inactivat ed SARS-CoV-2 Vaccine on a 0- and 14-day schedule;   Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule;   Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule;   Biological: Placebo on...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
By RAFAEL FONSECA, MD Reopening safely out of the current pandemic ought to be done via persuasion, not coercion. It has been more than five months since the world first learned about COVID-19. Models predicted a sharp increase in the number of cases, and a seemingly high likelihood the pandemic would overwhelm our hospitals. These models were often inaccurate, and we have all come to learn about the imprecision of epidemiological prediction.  Nevertheless, the infection is far worse than anyone initially accepted – becoming a staple of our generation. Fearing uncountable deaths and the possible need ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Health Policy Rafael Fonseca Source Type: blogs
The European Commission on Tuesday started a process that could lead to reforms of drug manufacturing to limit shortages of vaccines and antibiotics and make medicines more easily available.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More than a dozen Covid-19 vaccines are in development, but how much protection they may afford is still unknown.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news
More News: Alzheimer's | Complementary Medicine | Cough | Health | Science | Vaccines | Whooping Cough | Whooping Cough (Pertussis) Vaccine